A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Fortovase


Roche Posts Strong First Quarter Sales – Upgrade of Core Earnings ...  -  Apr 18, 2007
PharmaLive.com (press release),Sales of the HIV medicine Fuzeon increased by 12%, and Invirase/Fortovase by 23%. CellCept sales rose by 7% and remained the top-selling branded

YM BioSciences Strengthens Program Management of Lead Drugs  -  Apr 5, 2007
Drug Newswire (press release),La-Roche Inc. with leadership responsibility through NDA filings and certain of the approvals for Xeloda(TM), Fortovase(TM), Zenapax(TM), Xenical(TM).

Exploiting natural HIV defence  -  Feb 9, 2007
BiopharmaReporter.com,Next came HIV protease inhibitors such as Roche's Invirase/Fortovase (saquinavir), Abbott Laboratories Norvir (ritonavir), Merck & Co's Crixivan (indinavir)

Roche Posts Outstanding Results for 2006  -  Feb 7, 2007
PharmaLive.com (press release),Combined sales of Invirase and Fortovase (saquinavir) increased 28% to 182 million Swiss francs. Growth is being fuelled by increasing uptake of the

NGN Capital's Managing General Partner Georg Nebgen Joins Javelin ...  -  Dec 11, 2006
American Digital Networks (press release),...from F. Hoffmann-La Roche, where he led as Technical Project Leader global research & development team activities for Invirase/Fortovase.

Panacos Announces New Board Member  Oct 27, 2006
...was Medical Director for Hoffmann-LaRoche's Virology Group, where he was involved in the launch of INVIRASE and developed FORTOVASE, protease inhibitors for ... -PharmaLive.com (press release), NGN Capital’s Managing General Partner Georg Nebgen Joins Javelin ...  -  Dec 11, 2006
Business Wire (press release),...from F. Hoffmann-La Roche, where he led as Technical Project Leader global research & development team activities for Invirase/Fortovase.

Roche AIDS drug may be pulled out of India  Aug 10, 2006
...the wholly-owned subsidiary of Swiss drug maker F Hoffmann-La Roche & Co (Roche), is likely to withdraw its anti-HIV AIDS drug Fortovase (Saquinavir) from the ... -Financial Express

Roche to put AIDS drug off Indian shelves  Aug 10, 2006
After withdrawing its HIV AIDS drug from Europe, Roche India is likely to discontinue manufacturing the Fortovase (Saquinavir) from the Indian market as well ... -Myiris.com

Large analysis shows benefits of starting treatment with efavirenz  Aug 22, 2006
The boosted protease inhibitors included were amprenavir (Agenerase), lopinavir (Kaletra), saquinavir (Invirase / Fortovase) and indinavir (Crixivan): newer ... -Aidsmap

Roche discontinues marketing of anti-HIV drug Fortovase  Feb 8, 2006
Following through on plans announced in late 2005, drugmaker Roche on Monday halted US sales of its HIV protease inhibitor Fortovase, citing low demand for the ... - The Advocate,

Roche to Focus Resources on Availability of INVIRASE(R), Now ...  Feb 6, 2006
6 /PRNewswire/ -- Roche today announced that effective February 15, 2006, the company will discontinue the US sale and distribution of Fortovase(R), the soft ... - International News Service,

UPDATE 1-Roche to discontinue US sales of AIDS drug  Feb 6, 2006
YORK, Feb 6 (Reuters) - Roche Holding AG (ROG.VX: Quote, Profile, Research) said on Monday it will discontinue US sales of its HIV drug Fortovase as another ... - Reuters

Roche discontinues marketing of anti-HIV drug Fortovase  09 Feb 2006
Following through on plans announced in late 2005, drugmaker Roche on Monday halted US sales of its HIV protease inhibitor Fortovase, citing low demand for the ... - The Advocate

Roche to discontinue HIV treatment  09 Feb 2006
Swiss drug manufacturer Roche is to discontinue US sales of its HIV protease inhibitor Fortovase, a soft-gel formulation of the active ingredient saquinavir. ... - Pharmaceutical Business Review

Roche To Stop Selling Protease Inhibitor Fortovase Because of ...  Feb 8, 2006
15 it will stop selling its protease inhibitor Fortovase -- known generically as saquinavir -- in the US because of decreased demand for the drug and increased ... - Kaiser network.org

Roche to Focus Resources on Availability of Invirase, Now ...  Feb 6, 2006
February 6, 2006 -- Roche today announced that effective February 15, 2006, the company will discontinue the US sale and distribution of Fortovase®, the soft ... - DG News

Roche to Focus Resources on Availability of INVIRASE(R), Now ...  Feb 6, 2006
6 /PRNewswire/ -- Roche today announced that effective February 15, 2006, the company will discontinue the US sale and distribution of Fortovase(R), the soft ... - International News Service

UPDATE 1-Roche to discontinue US sales of AIDS drug  Feb 6, 2006
YORK, Feb 6 (Reuters) - Roche Holding AG (ROG.VX: Quote, Profile, Research) said on Monday it will discontinue US sales of its HIV drug Fortovase as another ... - Reuters

Roche to Focus Resources on Availability of INVIRASE(R), Now ...  Feb 6, 2006
...- Company Voluntarily Ceases Sale and Distribution of Fortovase(R) In the US - NUTLEY, NJ, Feb. 6 /PRNewswire/ -- Roche today announced ... - PR Newswire


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional